Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Journal of General Internal Medicine|April 10, 2015
Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured PopulationAaron S Kesselheim, Jessica M Franklin, Seoyoung C Kim, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 3, 2017
Fracture Risk After Bariatric Surgery: Roux-en-Y Gastric Bypass Versus Adjustable Gastric BandingElaine W Yu, Moa P Lee, Joan E Landon, et al.
JAMA Internal Medicine|May 7, 2019
Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring HemodialysisJulia Spoendlin, Julie M Paik, T Tsacogianis, et al.
American Journal of Nephrology|November 23, 2021
Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017Julie M Paik, Min Zhuo, Cassandra York, et al.
Pharmacoepidemiology and Drug Safety|September 9, 2021
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapyJulien Kirchgesner, Rishi J Desai, Maria C Schneeweiss, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 30, 2022
Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA: A Cohort Study from Longitudinal Electronic Health RecordsYinzhu Jin, Joan E Landon, Whitney Krueger, et al.
JAMA Surgery|May 16, 2019
Fracture Risk After Roux-en-Y Gastric Bypass vs Adjustable Gastric Banding Among Medicare BeneficiariesElaine W Yu, Seoyoung C Kim, Daniel J Sturgeon, et al.
JAMA Dermatology|March 28, 2019
Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic ArthritisMoa P Lee, Rishi J Desai, Yinzhu Jin, et al.
Seminars in Arthritis and Rheumatism|December 10, 2019
Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort studyEun Ha Kang, Yinzhu Jin, Rishi J Desai, et al.
The American Journal of Medicine|December 24, 2014
Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugsSeoyoung C Kim, Daniel H Solomon, Jun Liu, et al.
Pageof 19